SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
| FROM | TO | |
|---|---|---|
| ELIXINOL WELLNESS LIMITED | 19/05/2021 | |
| ELIXINOL GLOBAL LIMITED | 19/05/2021 |
Level 5, 126 Philip Street Sydney NSW 2000 GPO Box 5193 Sydney NSW 2001
Tel : 1300 288 664 or +61 2 9698 5414name changed to Elixinol Wellness Limited | 19/05/2021 |
The suspension of trading in the securities of Elixinol Global Limited will be lifted immediately following the release by EXL of an announcement regarding a binding agreement to acquire CannaCare Health GmbH. | 15/03/2021 |
Elixinol signs binding agreement to acquire CannaCare Health GmbH, owner of CANOBO, one of Germany's leading CBD brands with #1 share in Germany's drugstore channel. Expected to fast-track revenue and path to profitability growth for the Group. Proposed acquisition is highly synergistic, enabling consolidation of European supply chain, ability to leverage existing cost base and capabilities and expand the combined product portfolio into new geographies and categories. The combination of CannaCare with Elixinol's UK business is expected to create a pan-European business of scale, well positioned to capitalise on a burgeoning European CBD market. Follows recent down-scheduling of CBD in Europe and aligns with Elixinol's vision of becoming "a global, hemp derived health and wellness consumer products business". Elixinol Board to be strengthened with the addition of Frank Otto, CannaCare's major shareholder and media entrepreneur. Completion is subject to satisfaction of customary conditions precedent, approvals from the ASX and approval by Elixinol's shareholders, expected to be sought at the upcoming Annual General Meeting, anticipated to be held in mid-May 2021. Investor briefing to be held on Tuesday 16 March 2021 at 11:00am, AEDT. | 15/03/2021 |
The securities of Elixinol Global Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of EXL, pending the release of an announcement regarding a potential transaction. | 08/03/2021 |
listed entity carried for record purposes only | 08/01/2018 |
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 21/09/2023 | Pauline Gately | -3,349,581 | $0.007 | $23,447.00 |
| 18/10/2021 | Helen Wiseman | 112,000 | $0.091 | $10,192.00 |
| 29/09/2020 | Helen Wiseman | 79,896 | $0.155 | $12,384.00 |
| 28/09/2020 | Oliver Horn | 90,000 | $0.150 | $13,500.00 |
| 16/09/2020 | Paul Benhaim | -8,100,000 | $0.148 | $1,200,000.00 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| David Fenlon | Chairman | 28/03/2022 |
| Ron Dufficy | Managing Director, CEO | 08/01/2018 |
| Josephine Lorenz | CFO | 08/04/2022 |
| Pauline Gately | Non Exec Director, Company Secretary | 17/08/2023 |
| Tai Minh Phan | Company Secretary | 01/07/2024 |
| Melanie Leydin | Company Secretary | 01/07/2024 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|
Date of first appointment, title may have changed.
